APA (7th ed.) Citation

Musialek, P., Mazurek, A., Jarocha, D., Tekieli, L., Szot, W., Kostkiewicz, M., . . . Majka, M. (2015). Myocardial regeneration strategy using Wharton’s jelly mesenchymal stem cells as an off-the-shelf ‘unlimited’ therapeutic agent: Results from the Acute Myocardial Infarction First-in-Man Study. Postępy w kardiologii interwencyjnej, 2(2), 100-107. https://doi.org/10.5114/pwki.2015.52282

Chicago Style (17th ed.) Citation

Musialek, Piotr, et al. "Myocardial Regeneration Strategy Using Wharton’s Jelly Mesenchymal Stem Cells as an Off-the-shelf ‘unlimited’ Therapeutic Agent: Results from the Acute Myocardial Infarction First-in-Man Study." Postępy W Kardiologii Interwencyjnej 2, no. 2 (2015): 100-107. https://doi.org/10.5114/pwki.2015.52282.

MLA (9th ed.) Citation

Musialek, Piotr, et al. "Myocardial Regeneration Strategy Using Wharton’s Jelly Mesenchymal Stem Cells as an Off-the-shelf ‘unlimited’ Therapeutic Agent: Results from the Acute Myocardial Infarction First-in-Man Study." Postępy W Kardiologii Interwencyjnej, vol. 2, no. 2, 2015, pp. 100-107, https://doi.org/10.5114/pwki.2015.52282.